PF

Purdue Foundry Investment Fund

North America, Indiana, United States, West Lafayette

Description

Purdue Foundry Investment Fund provides matching funds for investments in Purdue startups.

Investor Profile

Purdue Foundry Investment Fund has made 4 investments, with 0 in the past 12 months and 75% as lead.

Stage Focus

  • Convertible Note (25%)
  • Seed (25%)
  • Grant (25%)
  • Series Unknown (25%)

Country Focus

  • United States (100%)

Industry Focus

  • Health Care
  • Wearables
  • Wellness
  • Marketing
  • Analytics
  • Predictive Analytics
  • Sensor
  • Biotechnology
  • Life Science
  • Medical
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Purdue Foundry Investment Fund frequently co-invest with?

Sidecar Angels
North America, Massachusetts, United States, Somerville
Co-Investments: 1
Purdue Foundry
North America, Indiana, United States, West Lafayette
Co-Investments: 1
Elevate Ventures
North America, Indiana, United States, Indianapolis
Co-Investments: 2
SWAN Impact Network
North America, Texas, United States, Dripping Springs
Co-Investments: 1

What are some of recent deals done by Purdue Foundry Investment Fund?

SpeechVive

Lafayette, Indiana, United States

SpeechVive is a medical technology company that specializes in providing a communication solution for people with Parkinson's Disease.

Health CareWearablesWellness
Convertible NoteJul 7, 2020
Amount Raised: $1,500,000
Physiq

Chicago, Illinois, United States

PhysIQ is a healthcare technology company that uses proprietary AI and wearable biosensors to monitor patients.

AnalyticsHealth CarePredictive AnalyticsSensorWearables
GrantJan 29, 2020
Amount Raised: $500,000
CommSense

West Lafayette, Indiana, United States

CommSense is a developer of sensor technology for smartphones.

Marketing
SeedMay 20, 2015
Amount Raised: $20,000
On Target Laboratories

Northbrook, Illinois, United States

On Target Laboratories engages in discovering, developing, and commercializing small molecules that target specific pathological

BiotechnologyLife ScienceMedical
Series UnknownMay 4, 2015
Amount Raised: $1,700,000